Login / Signup

Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.

Lauren V CollenVanessa MitsialisDavid Y KimMairead BresnahanJessica YangMargaret TuthillAbigail CombsJared BarendsMichael FieldEnju LiuRichelle BearupIbeawuchi OkoroaforChristoph KleinAleixo M MuiseAthos BousvarosJodie OuahedScott B Snapper
Published in: Inflammatory bowel diseases (2023)
Efficacy and safety of anti-TNFs in VEOIBD is comparable to what has previously been reported in older patients.
Keyphrases
  • early onset
  • late onset
  • rheumatoid arthritis